What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.34%Above 5Y avg (0.31%)
Annual Rate
CNY 0.03Paid unknown
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Jun 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.09BCNY
751.16M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue (TTM)
1.15BCNY
199.82M · vs all stocks (USD)
Updated Nov 22, 2026
Profit Margin
-17.11%
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Beta
0.5320x
vs all stocks
Updated Nov 22, 2026
52-Week Change
-58.28%
vs all stocks
Updated Nov 22, 2026
Forward Annual Dividend Yield
0.34%
vs all stocks
Updated Nov 22, 2026
Market Capitalization
4.09BCNY
751.16M · vs all stocks (USD)
Updated Nov 22, 2026
Enterprise Value
2.98BCNY
552.55M · vs all stocks (USD)
Updated Nov 22, 2026
Forward P/E
22.46x
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Price to Sales (TTM)
3.56x
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Price to Book (MRQ)
1.65x
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Enterprise to Revenue
2.59x
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Enterprise to EBITDA
-10.11x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 10.89×.Updated Nov 22, 2026
Gross Margin
29.84%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 51.38%.Updated Nov 22, 2026
Profit Margin
-17.11%
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Operating Margin
-22.07%
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Return on Assets (TTM)
-4.26%
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Return on Equity (TTM)
-7.43%
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Revenue (TTM)
1.15BCNY
199.82M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue per Share (TTM)
2.34CNYUpdated Nov 22, 2026
Quarterly Revenue Growth
-50.00%
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Gross Profit (TTM)
591.34MCNY
104.51M · vs all stocks (USD)
Updated Nov 22, 2026
EBITDA (TTM)
273.24MCNY
40.96M · vs all stocks (USD)
Updated Nov 22, 2026
Net Income (TTM)
-196.88MCNY
-14.04M · vs all stocks (USD)
Updated Nov 22, 2026
Quarterly Earnings Growth (YoY)
3.43%
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Operating Cash Flow (TTM)
58.92MCNY
13.67M · vs all stocks (USD)
Updated Nov 22, 2026
Levered Free Cash Flow (TTM)
195.28MCNY
28.41M · vs all stocks (USD)
Updated Nov 22, 2026
Forward Annual Dividend Rate
0.0300CNYUpdated Nov 22, 2026
Forward Annual Dividend Yield
0.34%
vs all stocks
Updated Nov 22, 2026
Trailing Annual Dividend Rate
0.0300CNYUpdated Nov 22, 2026
Trailing Annual Dividend Yield
0.34%
vs all stocks
Updated Nov 22, 2026
5-Year Average Dividend Yield
0.31%
vs all stocks
Updated Nov 22, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -7.89%.Updated Nov 22, 2026
Minority Interest (Equity)
1.62MCNYFY2025 · Dec 31, 2025
Revenue
1.51BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
634.85MCNYFY2025 · Dec 31, 2025
Gross Profit
874.26MCNYFY2025 · Dec 31, 2025
Operating Income
128.64MCNY
19.28M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
48.43MCNYFY2025 · Dec 31, 2025
Income Tax Expense
1.44MCNYFY2025 · Dec 31, 2025
Net Income
46.99MCNYFY2025 · Dec 31, 2025
EBIT
49.44MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
273.24MCNYFY2025 · Dec 31, 2025
Research & Development
280.26MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
126.64MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
10.70MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.30MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.01MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0951CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0950CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
492.59MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
492.59MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
46.99MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-141.10KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-284.21KCNYFY2025 · Dec 31, 2025
Free Cash Flow
-3.66MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
672.41MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
46.99MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
2.81MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-139.88MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
89.80MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-3.38MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-6.08BCNYFY2025 · Dec 31, 2025
Sale of Investments
5.93BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-149.04MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
198.41KCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.12MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-203.16KCNYFY2025 · Dec 31, 2025
Other Financing Charges
-10.92MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-12.05MCNYFY2025 · Dec 31, 2025
Shares Outstanding
492.77MSharesUpdated Nov 22, 2026
Float Shares
393.18MSharesUpdated Nov 22, 2026
% Held by Insiders
17.55%
vs all stocks
Updated Nov 22, 2026
% Held by Institutions
3.83%
vs all stocks
Updated Nov 22, 2026
Total Cash (MRQ)
1.02BCNY
159.42M · vs all stocks (USD)
Updated Nov 22, 2026
Total Cash per Share (MRQ)
2.13CNYUpdated Nov 22, 2026
Total Debt (MRQ)
23.16MCNY
3.90M · vs all stocks (USD)
Updated Nov 22, 2026
Total Debt to Equity (MRQ)
0.0096x
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Current Ratio (MRQ)
1.99x
vs Scientific & Technical Instruments peers
Updated Nov 22, 2026
Book Value per Share (MRQ)
5.05CNYUpdated Nov 22, 2026
Total Assets
3.90BCNY
585.24M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.59BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.23BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.31BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
23.29MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.20BCNYFY2025 · Dec 31, 2025
Cash
673.42MCNYFY2025 · Dec 31, 2025
Cash Equivalents
10.33MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
683.75MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
670.43MCNYFY2025 · Dec 31, 2025
Accounts Receivable
892.10MCNYFY2025 · Dec 31, 2025
Inventory
278.95MCNYFY2025 · Dec 31, 2025
Accounts Payable
369.22MCNYFY2025 · Dec 31, 2025
Short-term Debt
16.77MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
34.85MCNYFY2025 · Dec 31, 2025
Long-term Debt
11.15MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
492.77MCNYFY2025 · Dec 31, 2025
Retained Earnings
586.53MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.68BCNY
401.22M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
140.23MCNYFY2025 · Dec 31, 2025
52-Week Low
8.28CNYUpdated Nov 22, 2026
52-Week High
22.80CNYUpdated Nov 22, 2026
52-Week Change
-58.28%
vs all stocks
Updated Nov 22, 2026
Beta
0.5320x
vs all stocks
Updated Nov 22, 2026
50-Day MA
10.02CNYUpdated Nov 22, 2026
200-Day MA
12.83CNYUpdated Nov 22, 2026
Avg 10-Day Volume
8.53MSharesUpdated Nov 22, 2026
Avg 30-Day Volume
10.07MSharesUpdated Nov 22, 2026
Diluted EPS (TTM)
-0.3800CNYUpdated Nov 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -44.5%, lower than 95% of its Scientific & Technical Instruments peers (median 9%)Significant